Timing Cancer Treatment

1,782 views · Published 13 March 2016 · 3:23 · Indexed 8 November 2026

Channel: Harvard University · 2016 · Education

Watch on YouTube

There may be an ideal waiting period for delivering multiple cancer drugs

Researchers led by members of the Department of Systems Biology at Harvard Medical School had been studying how silencing MDMX, an oncogene, affected the dynamics of p53, a natural tumor suppressor, in cancer cells when they realized those dynamics might affect the cells’ sensitivity to a second, chemotherapy-like treatment.

Learn more at https://hms.harvard.edu/news/timing-matters

More from this channel